Shigeaki Muto
Overview
Explore the profile of Shigeaki Muto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
1295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muto S, Moriwaki K, Nagata D, Furuse M
Am J Physiol Renal Physiol
. 2024 Oct;
327(6):F1067-F1078.
PMID: 39480273
A considerable amount of NaCl reabsorption in proximal tubules (PTs) occurs via the paracellular transport regulated by the tight junction proteins claudins (Cldns). However, the paracellular transport properties in mouse...
2.
Nagano N, Tagahara A, Shimada T, Miya M, Tamei N, Muto S, et al.
Clin Exp Nephrol
. 2024 Aug;
28(12):1300-1310.
PMID: 39110345
Background: Elevated serum alkaline phosphatase (ALP) levels are a risk factor for all-cause mortality in hemodialysis patients. Traditionally in Japan, ALP measurements were conducted using the JSCC method, which yields...
3.
Nagano N, Zushida C, Tagahara A, Miya M, Tamei N, Muto S, et al.
Clin Exp Nephrol
. 2023 Aug;
27(11):961-971.
PMID: 37578637
Background: Dialysis patients often take multiple oral medications, leading to a high pill burden. Phosphate binders (PBs) account for a large proportion of this daily pill burden (DPB). The relationship...
4.
Masuda T, Muto S, Fukuda K, Watanabe M, Ohara K, Koepsell H, et al.
Physiol Rep
. 2020 Jan;
8(2):e14360.
PMID: 31994353
Most of the filtered glucose is reabsorbed in the early proximal tubule by the sodium-glucose cotransporter SGLT2. The glycosuric effect of the SGLT2 inhibitor ipragliflozin is linked to a diuretic...
5.
Akimoto T, Muto S, Kutsuwada T, Kutsuwada K, Nagata D
Clin Med Insights Case Rep
. 2019 Mar;
12:1179547619835176.
PMID: 30886527
An 86-year-old man who had been treated with peritoneal dialysis for 14°months due to end-stage kidney disease secondary to hypertensive nephrosclerosis presented with a recent history of malaise, abdominal discomfort,...
6.
Nagayama I, Masuda T, Nakagawa S, Murakami T, Ohara K, Matsuoka R, et al.
Intern Med
. 2019 Feb;
58(11):1587-1591.
PMID: 30713322
A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention...
7.
Ohara K, Masuda T, Murakami T, Imai T, Yoshizawa H, Nakagawa S, et al.
Nephrology (Carlton)
. 2018 Dec;
24(9):904-911.
PMID: 30578654
Aim: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are an antihyperglycemic drug with diuretic properties. We recently reported that an SGLT2 inhibitor ameliorated extracellular fluid expansion with a transient increase in urinary...
8.
Iwazu Y, Muto S, Ioka T, Watanabe Y, Iwazu K, Kusano E, et al.
Hypertension
. 2018 Oct;
72(3):776-784.
PMID: 30354753
We examined whether fingolimod (FTY720), an S1PR (sphingosine-1-phosphate receptor) modulator, has beneficial or harmful effects on mineralocorticoid/salt-induced renal injury. Uninephrectomized rats on 0.9% NaCl/0.3% KCl drinking solution were randomly divided...
9.
Murakami T, Akimoto T, Yamazaki T, Yoshizawa H, Okada M, Miki A, et al.
Clin Med Insights Case Rep
. 2018 Aug;
11:1179547618785137.
PMID: 30083060
A 28-year-old man was referred and admitted to our hospital due to O157-mediated hemorrhagic colitis with severe thrombocytopenia. A systemic workup concluded that the patient had acute pancreatitis as well...
10.
Murakami T, Akimoto T, Okada M, Hishida E, Sugase T, Miki A, et al.
Drug Target Insights
. 2018 Jul;
12:1177392818782899.
PMID: 30013310
A 66-year-old women with no history of renal disease was admitted due to a coma and acute kidney injury with a serum creatinine level of 7.44 mg/dL which were ascribed...